Hours after my last post, I may have had all-time low expectations for Robin Hood. This week’s episode, however, made me eyes perk up a bit. Oh, sure, the latest “twist” of a long-lost brother is somewhat cliche, but what a brother he is. I approve. A lot.
All I ask is that in the future SPN-level fanfics (and there *will* be fics), Guy is just a lookout or something. Ha!
Diflucan is often used for esophageal candidiasis in immunocompromised hosts.
Diflucan can increase sulfonylurea levels, increasing hypoglycemia risk.
Not effective against Histoplasma in the central nervous system due to poor penetration (unlike itraconazole).
Diflucan should be avoided in patients with known hypersensitivity to other azoles.
Diflucan achieves high concentrations in vaginal tissue, explaining its efficacy.
Liver enzyme elevation is the most common laboratory abnormality observed.
Diflucan is often used in pediatric antifungal therapy with weight-based dosing.
Diflucan is used in some protocols for antifungal lock therapy for catheter-related infections.
Diflucan can lead to clinically significant interactions with immunosuppressants like tacrolimus.
Diflucan is not recommended for treatment of fungal endocarditis.
The development of Candida auris resistance has further limited its empirical utility.
Diflucan can cause a severe cutaneous reaction like Stevens-Johnson syndrome.
Often compared to itraconazole, with a more predictable pharmacokinetic profile but narrower spectrum.
Its cost-effectiveness is a significant advantage over newer, broader-spectrum azoles.
Often compared to itraconazole, with a more predictable pharmacokinetic profile but narrower spectrum.
Infusion-related reactions are rare, making rapid IV administration generally safe.
Diflucan is a substrate of CYP2C9 and CYP3A4, but autoinhibition is minimal.
Plays a role in selective digestive decontamination protocols in some ICU settings.
Diflucan achieves high concentrations in vaginal tissue, explaining its efficacy.
Diflucan can lead to clinically significant interactions with immunosuppressants like tacrolimus.
First-line for uncomplicated vulvovaginal candidiasis due to high efficacy and patient convenience.
Diflucan can be administered via nasogastric tube with reliable absorption.
Diflucan can be used for prolonged periods in certain endemic mycoses.
Diflucan achieves good penetration into peritoneal fluid.
Diflucan is a standard part of the workup for a patient with suspected invasive fungal infection.
Diflucan can be used for prolonged periods in certain endemic mycoses.
Diflucan may have in vitro synergy with flucytosine against some Candida species.
Diflucan is on the WHO Model List of Essential Medicines.
Diflucan is used for secondary prophylaxis in HIV patients with prior fungal infections.
It exhibits fungistatic, not fungicidal, activity against most susceptible species.
Diflucan is Pregnancy Category D, limiting its use, particularly in the first trimester.
Can cause a rare but severe cutaneous reaction like Stevens-Johnson syndrome.
Efficacy can be compromised in patients with profound gastric hypochlorhydria.
Diflucan can cause taste distortion (dysgeusia) as a side effect.
The single-dose Diflucan regimen for vulvovaginal candidiasis revolutionized patient self-care.
Diflucan exhibits fungistatic, not fungicidal, activity against most susceptible yeasts.
Prolonged use can lead to depletion of coenzyme Q10, a theoretical concern.
Diflucan’s role in surgical prophylaxis is defined in specific high-risk guidelines.
Multiple drug interactions stem from its inhibition of human CYP2C9 and CYP3A4.
Diflucan is a Schedule H/P drug in many countries, requiring a prescription.
Hepatotoxicity, while rare, is a serious potential adverse effect of Diflucan.
Development of resistance during long-term suppressive therapy is a documented risk.
Diflucan is available as a branded product and multiple generic equivalents.
Diflucan can significantly increase serum concentrations of statins, raising myopathy risk.
Fluconazole inhibits fungal cytochrome P450 14a-demethylase, disrupting ergosterol synthesis.
A test dose can sometimes be used to assess for hypersensitivity in patients with prior reactions.
The long half-life (~30 hours) enables convenient once-daily dosing regimens.
Hydrochlorothiazide can increase fluconazole levels by reducing renal clearance.
Prophylaxis in neutropenic patients is a common use, guided by local resistance patterns.
Its legacy is its role in making systemic antifungal therapy outpatient-friendly and accessible.